WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 178,900 shares, a growth of 677.8% from the May 15th total of 23,000 shares. Based on an average trading volume of 75,100 shares, the short-interest ratio is currently 2.4 days.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft raised WuXi Biologics (Cayman) to a “buy” rating in a report on Thursday, March 27th.
Get Our Latest Analysis on WXXWY
WuXi Biologics (Cayman) Stock Up 4.9%
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.
Featured Articles
- Five stocks we like better than WuXi Biologics (Cayman)
- How to Evaluate a Stock Before Buying
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What to Know About Investing in Penny Stocks
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Top Stocks Investing in 5G Technology
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.